Release Date: 17/04/13 14:09 Summary: Allotment of Shares Pursuant to Rights Issue/Top 20 Price Sensitive: No Download Document 255.87KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%